Biotechnology double deals ... - Part 2

A string of US-listed biotechnology deals have been announced today.

They include: Boston Scientific's $3.7 billion acquisition of US-listed medical technology company Axonics and Merck's $680 million takeover of Harpoon Therapeutics.

Also, announced today was Johnson & Johnson's $2 billion acquisition of US-listed biopharmaceutical company Ambrx. Below is the link to that deal announcement:..